Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STMP
151
DELISTED
Stamps.com, Inc.
STMP
| $64.4M | 0.14% |
587,324
-73,297
| -11% | -$6.71M |
|
|
IDTI
152
DELISTED
Integrated Device Technology I
IDTI
| $64.3M | 0.14% |
2,441,653
-196,800
| -7% | -$5.04M |
|
|
ISBC
153
DELISTED
Investors Bancorp, Inc.
ISBC
| $64.1M | 0.14% |
5,151,987
+796,500
| +18% | +$10M |
|
154
Boston Scientific
BSX
$67.6B
| $64M | 0.14% |
+3,471,705
| New | +$62.2M |
|
155
SLB Ltd
SLB
$76.5B
| $63.8M | 0.14% |
914,593
+837,500
| +1,086% | +$62.7M |
|
156
Molina Healthcare
MOH
$10.4B
| $63.1M | 0.14% |
1,048,578
-35,900
| -3% | -$2.26M |
|
|
ARRS
157
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $62.4M | 0.14% |
2,042,720
| – | – |
|
|
VG
158
DELISTED
Vonage Holdings Corporation
VG
| $62.2M | 0.14% |
10,836,926
+51,100
| +0.5% | +$317K |
|
159
DuPont de Nemours
DD
$18.9B
| $62.1M | 0.14% |
476,385
+96,233
| +25% | +$12.4M |
|
160
Pinnacle West Capital
PNW
$12.8B
| $62M | 0.14% |
961,700
+197,100
| +26% | +$12.5M |
|
|
NUAN
161
DELISTED
Nuance Communications, Inc.
NUAN
| $62M | 0.14% |
3,600,892
+2,804,227
| +352% | +$45.5M |
|
162
DTE Energy
DTE
$30.6B
| $61.8M | 0.13% |
905,690
-42,849
| -5% | -$2.95M |
|
163
Factset
FDS
$9.46B
| $61.7M | 0.13% |
379,350
+100,550
| +36% | +$16.9M |
|
164
Arch Capital
ACGL
$36.3B
| $61.4M | 0.13% |
2,641,800
+198,300
| +8% | +$4.87M |
|
165
Lam Research
LRCX
$365B
| $60.8M | 0.13% |
7,651,560
-593,000
| -7% | -$4.46M |
|
166
Kinross Gold
KGC
$28.6B
| $60.1M | 0.13% |
33,042,099
+3,710,400
| +13% | +$7.33M |
|
|
MGLN
167
DELISTED
Magellan Health Services, Inc.
MGLN
| $60.1M | 0.13% |
974,799
+40,500
| +4% | +$2.17M |
|
168
Papa John's
PZZA
$997M
| $60M | 0.13% |
1,073,400
-56,600
| -5% | -$3.5M |
|
169
CorVel
CRVL
$3.08B
| $60M | 0.13% |
4,095,300
+147,000
| +4% | +$1.81M |
|
170
Intuitive Surgical
ISRG
$128B
| $59.6M | 0.13% |
982,530
-840,834
| -46% | -$47.2M |
|
|
ELNK
171
DELISTED
EarthLink Holdings Corp.
ELNK
| $59.5M | 0.13% |
8,014,439
+620,000
| +8% | +$5.21M |
|
172
Mid-America Apartment Communities
MAA
$15.5B
| $59M | 0.13% |
649,362
+46,100
| +8% | +$4.01M |
|
|
NTRI
173
DELISTED
NutriSystem, Inc.
NTRI
| $58.9M | 0.13% |
2,721,000
+455,289
| +20% | +$10.7M |
|
|
MXIM
174
DELISTED
Maxim Integrated Products
MXIM
| $58.8M | 0.13% |
1,548,100
-365,202
| -19% | -$14M |
|
175
Visa
V
$689B
| $58.8M | 0.13% |
757,700
-1,355,000
| -64% | -$105M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.